IL1B and cystic fibrosis: As discussed above (Wegiel et al., 2014a), by stabilizing HIF-1α and restoring IL-1β secretion, CO treatment may enhance the ability of host immune cells to better sense and eradicate P. aeruginosa isolates that are metabolically adapted to the CF lung environment.